[Efficiency of benazepril combined with wind dispelling and dampness removing chinese herbs on stage 3 chronic kidney disease with wind-dampness syndrome: a prospective study]
- PMID: 22686073
[Efficiency of benazepril combined with wind dispelling and dampness removing chinese herbs on stage 3 chronic kidney disease with wind-dampness syndrome: a prospective study]
Abstract
Objective: To observe the clinical efficiency and safety of Benazepril and wind dispelling and dampness removing Chinese herbs were singly or combined used in patients with stage 3 chronic kidney disease (CKD 3), and to provide effective integrative medicine methods for treatment of CKD 3.
Methods: The CKD 3 was allocated to qi and yin deficiency syndrome, inner disturbance of wind and damp syndrome, stasis in Shen meridian syndrome, and inner accumulation of damp and heat syndrome. Recruited were patients of inner disturbance of wind and damp syndrome accompanied or unaccompanied with the other 3 syndrome types. In the prospective, randomized, double blind controlled study, 60 patients confirmed as primary chronic glomerulonephritis (CGN) were randomly assigned to 3 groups with a total course of treatment for 24 weeks. Patients in the Western medicine group (WM, 23 cases) took Benazepril (10 mg/d). Those in the Chinese medicine group (CM, 20 cases) received treatment by syndrome typing. Those in the combination group (17 cases) used the two methods. The therapeutic efficacy and the occurrence of adverse reactions were observed in the 3 groups.
Results: The inner disturbance of wind and damp syndrome accompanied qi and yin deficiency syndrome and stasis in Shen meridian syndrome was most often seen in these patients. It accounted for 75.0% in the CM group, 60.9% in the WM group, and 82.4% in the combination group. Totally 54 patients completed this trial. Of them, there were 19 in the CM group, 19 in the WM group, and 16 in the combination group. There was no significant difference in the total effective rate of Chinese medicine syndrome among the 3 groups (84.2%, 78.9%, and 87.5%, respectively) (P>0.05). As for the total effective rate of WM, it was obviously higher in the combination group than in the WM group and the CM group (100.0%, 94.7%, and 94.7%, respectively) (P<0.05). The ratio (24 weeks of treatment/pre-treatment ratio) of serum creatinine (SCr) was obviously higher in the WM group than in the combination group (P<0.05), the estimate glomerular filtration rate (eGFR) (24 weeks of treatment/pre-treatment ratio) was obviously lower in the WM group than in the combination group (P<0.05). There was no statistical difference in SCr and eGFR between the CM group and the combination group. The mean and median of 24 h urine protein ratio (24 weeks of treatment/pre-treatment ratio) were less in the combination group than in the other two groups. The urine protein greater than 2.0 g/d occurred in no case. The experimental drug-correlated adverse reaction rate was obviously higher in the WM group than in the CM group (30.4% vs 10.0%, P<0.05).
Conclusions: As for CGN CKD 3 patients, treatment by Benazepril combined with wind dispelling and dampness removing Chinese herbs showed favorable renal protective effects. It delayed the progress of renal failure, significantly improve the overall clinical efficacy. It was an effective treatment method for CGN CKD 3 patients with good patient tolerance and less adverse reactions.
Similar articles
-
[Long-term Effect of the Treatment of IgA Nephropathy by Tonifying Shen, Activating Blood Stasis, Dispelling Wind-Dampness Combined with Western Medicine].Zhongguo Zhong Xi Yi Jie He Za Zhi. 2017 Jan;37(1):28-33. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2017. PMID: 30695421 Chinese.
-
Optimized project of traditional Chinese medicine in treating chronic kidney disease stage 3: a multicenter double-blinded randomized controlled trial.J Ethnopharmacol. 2012 Feb 15;139(3):757-64. doi: 10.1016/j.jep.2011.12.009. Epub 2011 Dec 13. J Ethnopharmacol. 2012. PMID: 22178174 Clinical Trial.
-
[Therapeutic effect of Astragalus and Angelica mixture on the renal function and TCM syndrome factors in treating stage 3 and 4 chronic kidney disease patients].Zhongguo Zhong Xi Yi Jie He Za Zhi. 2014 Jul;34(7):780-5. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2014. PMID: 25137839 Clinical Trial. Chinese.
-
Efficacy and safety of activating blood circulation and removing blood stasis of Traditional Chinese Medicine for managing renal fibrosis in patients with chronic kidney disease: a systematic review and Meta-analysis.J Tradit Chin Med. 2023 Jun;43(3):429-440. doi: 10.19852/j.cnki.jtcm.20230308.003. J Tradit Chin Med. 2023. PMID: 37147744 Free PMC article.
-
[Chinese medicine for acute upper respiratory tract infection: a systematic review of randomized controlled trials].Zhong Xi Yi Jie He Xue Bao. 2009 Aug;7(8):706-16. doi: 10.3736/jcim20090802. Zhong Xi Yi Jie He Xue Bao. 2009. PMID: 19671407 Chinese.
Cited by
-
Efficacy and Safety of Chinese Herbal Formula Granules in Treating Chronic Kidney Disease Stage 3: A Multicenter, Randomized, Placebo-Controlled, Double-Blind Clinical Trial.Evid Based Complement Alternat Med. 2020 Oct 21;2020:4073901. doi: 10.1155/2020/4073901. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 33144869 Free PMC article.
-
Efficacy and safety of the Fu-Zheng-Qu-Zhuo method on retarding the progress of chronic kidney disease (stage 3-4): a systematic review and meta-analysis.Ann Transl Med. 2019 Mar;7(6):114. doi: 10.21037/atm.2018.12.29. Ann Transl Med. 2019. PMID: 31032269 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous